Clin2
NCT06685536Likely a fitEnrolling by invitation

Long-term follow-up for CS-101 recipients

Beta-Thalassemia

Part of Blood & lymphatic, Genetic & congenital clinical trials.

This study follows up on people who have already received the CS-101 infusion in a previous trial. It aims to check how participants are doing over time. There are no restrictions to join if you already received CS-101.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
5 people
Ages
6 years to 35 years
Study type
Observational

Who can take part

  • You must have already received the CS-101 infusion in a past study.
  • You (or your legal guardian or representative) must sign a consent form agreeing to join.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06717932Enrolling by invitation
Long-term safety study of CS-101 injection

This study follows up with people who already received the CS-101 injection in a previous trial to check its safety and how well it works over time.

Nanning
NCT06328764Enrolling by invitation· Early Phase 1
CS-101 for patients with beta-thalassemia

This trial tests a new treatment called CS-101 for people with beta-thalassemia who need regular blood transfusions. It aims to see if CS-101 can help reduce transfusion needs.

Nanning, Guangxi
NCT06772766Recruiting· Phase 1
Study of 9MW3011 in adults with beta-thalassemia without regular transfusions

This trial tests a new drug, 9MW3011, in people with a type of beta-thalassemia that does not require regular blood transfusions. The goal is to see if the drug can safely help manage iron overload and improve hemoglobin levels.

Nanning, Guangxi
NCT06479616Recruiting
Long-term follow-up for CS-101 recipients

This study checks on participants who previously received the experimental treatment CS-101. It aims to track their health over time to see how safe and effective the treatment is in the long run.

Shanghai, Shanghai Municipality
NCT04208529Enrolling by invitation· Phase 3
Long-term follow-up after receiving CTX001 infusion

This study follows people for a long time after they received CTX001 in an earlier (parent) study. It helps researchers learn about long-term safety and outcomes of the treatment.

Palo Alto, California
NCT06271512Recruiting
Follow-up study for beta-thalassemia patients treated with beti-cel

This study is for people with beta-thalassemia who have already received the gene therapy betibeglogene autotemcel (beti-cel). It collects information to learn how patients are doing after this treatment in real-world settings.

Oakland, California

Hear when a new Beta-Thalassemia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.